UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 04,
Telesis Bio (NASDAQ:TBIO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Telesis Bio Charts.
Telesis Bio (NASDAQ:TBIO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Telesis Bio Charts.

Translate Bio, Inc. News

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
Thursday 18 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 30 November 2023 (5 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 13 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 13 November 2023 (6 months ago) • Edgar (US Regulatory)

More Translate Bio, Inc. News Articles